Second, our results confirmed the general involvement of Rictor in HCC in both rat models and human specimens, and illustrated Rictor as a potent oncogenic molecule contributing to p53wt deactivation in hepatocytes. Here, RICTOR is linked to hepatocellular carcinoma.